FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
27 August 2026
No Comments
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for
Tag: RAS inhibitor